Donepezil hydrochloride and rivastigmine are prescribed cholinesterase inhibitors that reversibly inhibit synaptic acetylcholinesterases, enhancing cholinergic transmission in AD patients [88,89]. The gene discussed is BCHE; the disease is Alzheimer disease.